XML 55 R40.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Financial Instruments (Tables) | 12 Months Ended
--- | ---
Dec. 30, 2023
Investments, All Other Investments [Abstract] |
Schedule of Fair Values of Derivative Instruments Included within Accompanying Consolidated Balance Sheets | The fair values of derivative instruments included within the accompanying Consolidated Balance Sheets as of 2023 and 2022 year end are as follows:
|  |  |  | 2023 |  | 2022
(Amounts in millions) |  | Balance Sheet Presentation |  | Derivative Assets Fair Value |  | Derivative Liability Fair Value |  | Derivative Assets Fair Value |  | Derivative Liability Fair Value
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |
Foreign currency forwards |  | Prepaid expenses and other current assets |  | $ | 17.9 |  |  | $ | — |  |  | $ | 18.5 |  |  | $ | — |
Foreign currency forwards |  | Other accrued liabilities |  | — |  |  | 11.9 |  |  | — |  |  | 16.9 |
Equity forwards |  | Prepaid expenses and other current assets |  | 19.9 |  |  | — |  |  | 14.8 |  |  | — |
Total derivative instruments |  |  |  | $ | 37.8 |  |  | $ | 11.9 |  |  | $ | 33.3 |  |  | $ | 16.9 |
Schedule of Effect of Derivative Instruments Designated as Fair Value and Cash Flow Hedges Included in the Consolidated Statements of Earnings | The effect of derivative instruments designated as fair value and cash flow hedges as included in the Consolidated Statements of Earnings is as follows:
|  | Gain (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
|  | 2023 |  | 2022 |  | 2021
(Amounts in millions) | Interest expense |  | Other income (expense) – net |  | Interest expense |  | Other income (expense) – net |  | Interest expense |  | Other income (expense) – net
Total amounts of income and expense presented in the Consolidated Statements of Earnings: |  | $ | (49.9) |  |  | $ | 67.5 |  |  | $ | (47.1) |  |  | $ | 42.5 |  |  | $ | (53.1) |  |  | $ | 16.5 |
Gain (loss) on fair value hedging relationships: |  |  |  |  |  |  |  |  |  |  |  |
Interest rate swaps |  |  |  |  |  |  |  |  |  |  |  |
Long-term debt |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (10.2) |  |  | $ | — |
Derivatives designated as hedging instruments |  | — |  |  | — |  |  | — |  |  | — |  |  | 2.7 |  |  | — |
Gain on cash flow hedging relationships: |  |  |  |  |  |  |  |  |  |  |  |
Treasury locks |  |  |  |  |  |  |  |  |  |  |  |
Gain reclassified from accumulated OCI into income |  | $ | 1.6 |  |  | $ | — |  |  | $ | 1.6 |  |  | $ | — |  |  | $ | 1.6 |  |  | $ | — |
Schedule of Derivative Instruments Not Designated as Hedges Included in Consolidated Statements of Earnings | The effects of derivative instruments not designated as hedging instruments as included in the Consolidated Statements of Earnings are as follows:
|  | Statement of Earnings Presentation |  | Gain (Loss) Recognized in Income on Derivatives
(Amounts in millions) |  |  |  | 2023 |  | 2022 |  | 2021
Gain (loss) on derivative relationships: |  |  |  |  |  |  |  |
Foreign currency forwards |  | Other income (expense) – net |  | $ | 6.0 |  |  | $ | (17.6) |  |  | $ | (10.8) |
Net exposures |  | Other income (expense) – net |  | (17.0) |  |  | 10.1 |  |  | 9.6 |
Equity forwards |  | Operating expenses |  | $ | 4.5 |  |  | $ | 1.4 |  |  | $ | 4.1 |
Stock-based deferred compensation liabilities |  | Operating expenses |  | (4.5) |  |  | (1.4) |  |  | (4.3) |
Schedule of Fair Values of Financial Instruments Not Approximating Carrying Values in Financial Statements | The fair values of financial instruments that do not approximate the carrying values in the financial statements as of 2023 and 2022 year end are as follows:
|  | 2023 |  | 2022
(Amounts in millions) |  | Carrying Value |  | Fair Value |  | Carrying Value |  | Fair Value
Finance receivables – net |  | $ | 1,878.3 |  |  | $ | 2,138.7 |  |  | $ | 1,733.0 |  |  | $ | 1,983.9 |
Contract receivables – net |  | 528.7 |  |  | 561.6 |  |  | 493.7 |  |  | 520.4 |
Long-term debt and notes payable |  | 1,200.2 |  |  | 1,031.5 |  |  | 1,201.0 |  |  | 982.1 |

X
- Definition Schedule of derivative instrument not designated as hedge instrument recognized in statement of earning. + References No definition available. + Details
Name: | sna_ScheduleOfDerivativeInstrumentNotDesignatedAsHedgeInstrumentRecognizedInStatementOfEarningTableTextBlock
Namespace Prefix: | sna_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-11 + Details
Name: | us-gaap_FairValueByBalanceSheetGroupingTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration